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Abstract 
Background: Cannabis has an adverse effect on the ability to drive safely, therefore a rapid disposable test for Δ9‑
tetrahydrocannabinol (Δ9‑THC), the psychoactive component of cannabis, is highly desirable for roadside testing.
Results: A screen printed carbon electrode is used for the N‑(4‑amino‑3‑methoxyphenyl)‑methanesulfonamide 
mediated detection of Δ9‑THC in saliva. Mediator placed in an overlayer was galvanostatically oxidized and reacted 
with Δ9‑THC to give an electrochemically active adduct which could be detected by chronoamperometric reduction. 
Detection of 25‑50 ng/mL Δ9‑THC spiked into undiluted saliva was achieved with a response time of 30 s. A trial of the 
sensors with four cannabis smokers showed sensitivity of 28 %, specificity of 99 % and accuracy of 52 %.
Conclusions: Rapid electrochemical detection of Δ9‑THC in undiluted saliva has been demonstrated using a dispos‑
able sensor, however the sensitivity is lower than acceptable. Further optimization of the assay and sensor format is 
required to improve the sensitivity of response to Δ9‑THC.
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Background
In the United Kingdom a 2010 report commissioned 
by the Department of Transport stated that most drug 
driving in the UK goes undetected [1]. Two thirds of US 
trauma centre admissions are due to motor vehicle acci-
dents with almost 60 % of such patients testing positive 
for drugs or alcohol [2]. Cannabis, cocaine and meth-
amphetamine are the drugs most frequently detected in 
drivers randomly stopped for roadside drug screening 
[3–6]. These drugs are frequently abused as recreational 
drugs due to their stimulant and euphoric effects. Canna-
bis causes euphoria, somnolence, a change of visual and 
auditory perception and a decrease in psychomotor abili-
ties. The danger is markedly increased when cannabis is 
combined with alcohol, which seems to be the case quite 
frequently. Driving a vehicle while under the influence of 
cannabis is thus clearly undesirable.
Onsite testing for cannabis and in particular its primary 
active ingredient Δ9-tetrahydrocannabinol (Δ9-THC) is 
routinely performed in urine. Urine testing is not prac-
ticable for the roadside screening of a potential drug 
driver for detecting recent drug use. Oral fluid which 
contains saliva and other liquid substances present in the 
oral cavity are of great interest for roadside drug screen-
ing. The roadside tests using oral fluid are mainly lateral 
flow immunoassay systems. Although oral fluid is easy 
to collect there is considerable inter-sample variability 
in the fluid matrix that provides issues when developing 
a testing methodology. The pan-European research pro-
ject called DRUID (Driving under the Influence of Drugs, 
Alcohol and Medicines) have called for better screens for 
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cannabis [7]. Testing Δ9-THC using four on-site oral fluid 
drug testing devices gave clinical sensitivities varying 
between 23 and 81 % [8].
Roadside testing for drugs of abuse has a number of 
requirements: it needs to be fast, ideally 15–30 s, the same 
speed as a breath alcohol test, very sensitive, ideally <10 ng/
ml (31 nM), it should be non-invasive, with built in controls, 
difficult to tamper with and be portable. A further important 
criteria is that the test must be easy to perform by non-lab-
oratory personnel. Some lateral flow devices can give false 
positive results if they are not kept horizontal during the 
test procedure. Currently available drug screening products 
require a minimum of 5–9 min for a test. Test time and cost 
are currently restricting the roadside drug screening market 
to <10 % the volume of the alcohol screening market.
The global drug of abuse testing market was valued at 
$2.9B in 2014. This market is expected to grow at a CAGR 
of 5.3 % during 2015–2020, to reach $3,9B by 2020, with 
North America taking the largest market share. The 
onsite testing market is double the size of the laboratory 
testing market. In Europe onsite testing had a market size 
of $346 M in 2014 [9].
Screen printed electrodes are in common use for quick, 
cheap, disposable tests for a variety of analytes, in par-
ticular for measuring blood glucose. Screen printed 
electrodes are commercially available from a number of 
suppliers e.g. Dropsens (Spain), Gwent Electronic Mate-
rials (UK) and Conductive Technologies Inc. (USA). The 
application of screen printed electrodes to the detection 
of drugs of abuse in saliva is therefore of great interest.
There has been few reports of the electrochemical sens-
ing of Δ9-THC. The direct electrochemistry of Δ9-THC 
has been reported by absorptive striping voltammetry 
at a carbon paste electrode [10], and by square wave vol-
tammetry at a glassy carbon electrode [11] and at a par-
affin-impregnated graphite electrode [12]. In all cases, 
pre-concentration of Δ9-THC onto the electrode was 
required to maximize sensitivity. The indirect detection 
of Δ9-THC has been reported using substituted phenols 
as an electrochemical adaption of the Gibbs reaction [13, 
14]. The authors are not aware of any reports of electro-
chemical detection of Δ9-THC in real saliva.
This paper reports a mediated screen printed carbon 
electrode for the detection of Δ9-THC in undiluted saliva 
using N-(4-amino-3-methoxyphenyl)-methanesulfona-
mide mediator. The sensor is optimized for response to 
Δ9-THC in undiluted saliva.
Results and discussion
Reaction of mediator with Δ9‑THC
The structures of N-(4-amino-3-methoxyphenyl)-meth-
anesulfonamide (OX0245) and Δ9-THC are shown in 
Fig. 1. The reaction mechanism is shown in Fig. 2 for the 
reaction between OX0245 and a phenol [15]. Electro-
chemical oxidation of OX0245 results in oxidation to the 
diimine, which then reacts with Δ9-THC at the 4-posi-
tion on the phenolic ring, forming an adduct which has 
two resonance structures, III and IV. The adduct itself 
can be electrochemically reduced via the diimine of reso-
nance structure IV, and therefore the response to Δ9-THC 
is observed as an increase in reduction current at the 
diimine reduction potential, since THC, and therefore 
also the adduct, are relatively insoluble and readily adsorb 
onto the electrode, giving an enhanced reduction current 
in addition to the reduction current arising unreacted 
mediator II which has diffused to the electrode surface.
A single reduction peak is obtained, since the reduction 
potentials for the diimine of the parent mediator and the 
adduct are similar. It is unlikely that the quinone form of 
the adduct III will undergo reduction since it is reported 
that the quinone form of THC does not undergo electro-
chemical reduction [12].
The cyclic voltammetry of OX0245 is shown in Fig. 3, 
using screen printed sensors with the format shown 
in Fig. 4a. The sensors consisted of a two electrode sys-
tem using a carbon working electrode surrounded by 
Fig. 1 Structures of the mediator OX0245 and Δ9‑THC
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a combined Ag/AgCl reference/counter electrode. The 
parent mediator shows good reversible electrochemis-
try, undergoing oxidation/reduction at +0.059  V and 
−0.005 V. The reduction peak height increased by 25 % in 
the presence of 100 ug/mL Δ9-THC.
Sensor construct
For a simple disposable device it was desired that the 
mediator and buffer solution be dried down in some 
way on the sensor. One way of achieving this would be 
to deposit mediator solution directly onto the sensor 
and evaporate the solvent, so that on application of sam-
ple the mediator would dissolve into the sample. Alter-
natively, the mediator solution could be dried onto a 
porous overlayer which is then secured over the sensor. 
On application of sample, the mediator dissolves and dif-
fuses to the working electrode where it can undergo reac-
tion. Deposition requires tight control of the volume and 
position of the dispensed reagent, therefore an overlayer 
is preferred and was used in the prototype sensor.
The sensor was constructed by placing a dried reagent 
overlayer containing mediator, buffer, salt and surfactant 
over the electrodes, as shown in Fig.  4b. On applying 
sample to one end of the membrane, the sample wicked 
along the overlayer, wetting the reagents and the elec-
trode surfaces. OX0245 has good solubility of at least 
1 mg/mL in pH 9.5 buffer, and hence it dissolved off the 
overlayer rapidly.
Initial electrochemical procedure
Initially the procedure consisted of (1) trigger; (2) wait 
time; (3) galvanostatic oxidation (G) and (4) chrono-
amperometric reduction (CA).
The test procedure was commenced with an electro-
chemical trigger, using the cut-off function within the 
Nova software of the Autolab instrument. The cut-off 
consisted of an applied potential of −0.3  V with a time 
Fig. 2 Mechanism for the reaction between OX0245 and phenol
Fig. 3 Cyclic voltammetry of OX0245 in the absence or presence 
of Δ9‑THC. 15 uL of solution containing 100 ug/mL OX0245 in 0.4 M 
AMPSO (pH 9.5), 1 M NaCl, 10 % methanol and (A) 0 or (B) 100 ug/mL 
Δ9‑THC was pipetted onto the sensor. The start potential was −0.4 V 
and the scan rate was 50 mV/sec
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limit of 100  s. The next step of the procedure was trig-
gered when the working electrode current was greater 
than −100 nA, which typically took 5–10 s after applica-
tion of sample to the overlayer.
The sensor was used in a two electrode format with a 
combined counter/reference electrode since it was found 
that the sensor was more uniformally wetted at the trig-
ger time with a two electrode system compared to a three 
electrode system, where the sensor was sometimes only 
partially wetted.
The trigger was followed by a wait time, to allow the 
dried reagents on the overlayer to fully wet up and reach 
the electrode. During the wait time, the working elec-
trode was at open circuit potential, which typically sta-
bilized at –0.04 V. It was found that more viscous saliva 
samples took longer to completely wet the overlayer, and 
a wait time of 20 s was chosen to ensure complete wet-
ting of the overlayer.
The wait time was followed by G for 5  s and CA at 
−0.2  V for 2  s. Galvanostatic oxidation was selected 
in preference to potentiostatic oxidation since the 
mediator concentration adjacent to the working elec-
trode may vary from sensor to sensor, since it will be 
dependent on the consistency of coverage of mediator 
on the overlayer and the rate of diffusion of reduced 
mediator from the overlayer to the electrode surface, 
which in turn can vary with the viscosity of the saliva 
sample. Variation in the mediator concentration at the 
electrode surface will result in a variable amount of oxi-
dized mediator being produced during potentiostatic 
oxidation, since the rate of oxidation will be dependent 
directly on mediator concentration as described by the 
Cottrell equation.
Galvanostatic oxidation requires there to be sufficient 
mediator present to ensure oxidation of only the media-
tor. Insufficient mediator would result in oxidation of any 
other oxidizable species present, such as phenolic groups 
at the carbon electrode surface. Therefore a high media-
tor loading of 1  mg/mL was used on the overlayer. The 
magnitude of the shift in potential of the working elec-
trode during the G step gives an indication of whether 
there is sufficient mediator available. Excessively large 
potential shifts indicate insufficient mediator.
There are relatively few examples of galvanostatic oxi-
dation to generate reactant in the literature. Tomcik 
et al. have reported the galvanostatic generation of hypo-
bromite at an interdigitated microelectrode array, for 
end-point titration of the drugs Antabus and Celaskon, 
although this used separate generator-collector elec-
trodes [16]. In our application, the working electrode is 
used to both generate the reactant (oxidized mediator) 
and detect the mediator -THC adduct.
The response to saliva obtained from nine donors using 
G-CA is shown in Fig.  5a. The procedure used (1) trig-
ger; (2) wait time; (3) G of 100 nA for 5 s and (4) CA at 
−0.2 V for 2 s. For each sensor response, the average CA 
current during the specified time periods was calculated. 
Each sample was tested with several sensors, and the 
average of these sensor responses over the specified time 
periods is shown in the Figure. There is some variation 
in the chronoamperometric responses observed between 
samples from different donors. This was thought due to 
Fig. 4 Screen printed electrode (a) without and (b) with overlayer applied. The sensor comprised the ovalular carbon working electrode (3.2 mm 
length, 1.2 mm width) and outer concentric Ag/AgCl counter/reference electrode
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interferents in the samples producing an extra reduction 
current, and possibly also due to variations in the sensor 
construct.
Optimization of electrochemical procedure
To overcome the donor variation in response, an extra 
initial chronoamperometric step was introduced, at the 
same potential as the final chronoamperometric step, so 
that subtraction of the first transient current response 
from the final transient current response would correct 
for any interferent response. However this first chrono-
amperometric step also introduced some variability in 
final CA response, since the first CA step took place at 
−0.2  V, whereas the open circuit potential at the start 
of the galvanostatic step was typically −0.04  V. It was 
found that on switching to open circuit potential from an 
applied potential of −0.2 V, it took approximately 2 s for 
the electrode potential during the galvanostatic step to 
reach −0.04 V. It is unknown whether any species were 
being oxidized during this period, and it may be that 
Fig. 5 Response to saliva from nine donors using G‑CA or CA1‑CA2‑G‑CA3. a CA response from G‑CA and b CA3‑CA1 response from CA1‑CA2‑
G‑CA3. Each data point is the average response of 12 sensors, averaged over the time intervals 0.0–0.025, 0.025–0.05, 0.05–0.075, 0.075–0.1 and 
0.1–0.125 s. The error bars are one standard deviation. The overlayer was coated with 1 mg/mL OX0245 in 0.4 M AMPSO (pH 9.5), 1 M NaCl, 1 % 
TX‑100 and 0.5 % Surfynol 465. 7 uL of saliva obtained from one donor was applied to each sensor. The G‑CA procedure was 20 s wait time, galvano‑
static current of 100 nA for 5 s, followed by chronoamperometric reduction at −0.2 V for 2 s. The CA1‑CA2‑G‑CA3 procedure was 20 s wait time, CA1 
at −0.2 V for 2 s, CA2 at −0.04 V for 0.5 s, galvanostatic current of 100 nA for 5 s, followed by CA3 at −0.2 V for 2 s
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oxidation was primarily of surface groups on the carbon 
electrode.
Consequently an extra CA step was introduced 
between the first CA step and the G step. This second 
chronoamperometric step was at −0.04  V and of 0.5  s 
duration, the intention being to poise the electrode 
potential at the typical open circuit potential for the start 
of the galvanostatic step.
The final electrochemical procedure was as follows: (1) 
trigger; (2) wait time of 20 s; (3) CA1 at −0.2 V for 2 s; 
(4) CA2 at −0.04 V for 0.5 s; (5) G at 100 nA for 5 s and 
(6) CA3 at −0.2 V for 2 s. Subtraction of CA1 from CA3 
for each sensor should allow correction for any interfer-
ent response.
The response to saliva from nine donors using 
CA1-CA2-G-CA3 is shown in Fig.  5b (these are the 
same saliva samples used in Fig. 5a). There was a signifi-
cant reduction in %CV when using CA3-CA1 currents 
obtained using CA1-CA2-G-CA3, compared to the CA 
current using CA-G, as shown in Table 1.
The advantage of G is demonstrated in Fig.  6, which 
shows the CA3-CA1 response to different concentrations 
of OX0245 when using potentiostatic or galvanostatic oxi-
dation. On increasing the mediator concentration from 0.1 
to 2  mg/mL there is a 380  % increase in chronoampero-
metric (CA) current at the first time point (0.05–0.15  s) 
when using potentiostatic oxidation, compared to a 13  % 
decrease in CA current when using galvanostatic oxidation.
The effect of the magnitude of the galvanostatic cur-
rent on CA3-CA1 response was investigated using 
saliva from a single donor, shown in Fig.  7. The CA3-
CA1 current was linearly dependent on the galvano-
static current from 25 to 300  nA, showing that good 
control of the oxidation process was occurring. A galva-
nostatic current of 100 nA was selected since this gave 
a measurable CA response compared to no G, while 
a higher galvanostatic current would result in higher 
baseline CA current against which the response to Δ9-
THC would have to be determined. This could reduce 
the accuracy of the device if the Δ9-THC response was 
a small current change on a large background current 
response obtained in the absence of Δ9-THC.
Response to Δ9‑THC in undiluted saliva
The CA3-CA1 response to saliva from a single donor 
spiked with Δ9-THC in 10  % methanol using the 
CA1-CA2-G-CA3 procedure is shown in Fig. 8. There is a 
small increase in current in response to 10 and 25 ng/mL 
THC compared to 0  ng/mL. The current response then 
shows no change between 25 and 100  ng/mL, although 
there is possibly a further small decrease at 250 ng/mL.
It would appear that the sensor is sensitive to low con-
centrations of Δ9-THC. This may be a reflection of the 
availability of Δ9-THC for reaction with the oxidized 
mediator. Δ9-THC is lipophilic and is largely protein 
bound in biological fluids. Although the overlayer con-
tains Triton and Surfynol surfactants, these may be insuf-
ficient or too slow acting to release all the Δ9-THC from 
protein within the response time of the sensor.
Trial of the sensors using fresh samples from cannabis 
smoking donors
A trial of the sensors was conducted at SWOV Institute 
for Road Safety Research in The Hague using saliva col-
lected from four cannabis smoking volunteers. The Δ9-
THC concentrations determined by LC/MSMS of the 
samples collected from the cannabis smoking donors are 
shown in Fig. 9. The samples show a typical time depend-
ent response after smoking. The samples contained a 
range of Δ9-THC concentrations with which the sensors 
could be tested. Fourteen samples were also collected 
from non-smoking donors which had negligible concen-
trations of Δ9-THC.
Each sample was designated negative (0  ng/mL) or 
positive (>0 ng/mL) according to the LC/MSMS results. 
The sensor performance was characterized for sensitivity, 
specificity and accuracy of response.
A cut-off value for the current was calculated using the 
CA3-CA1 current responses for samples containing 0 ng/
mL Δ9-THC. The cut-off was defined as the average CA3-
CA1 current plus 2 standard deviations. Based on this 
cut-off and the sample Δ9-THC concentrations deter-
mined by LC/MSMS, each individual sensor response 
was assigned as either TN, TP, FN or FP (true negative, 
true positive, false negative or false positive) i.e. a true 
negative or false positive sensor response had a sample 
Δ9-THC concentration of 0 ng/mL as determined by LC/
MSMS and current response either below or above the 
cut-off; a true positive or false negative sensor response 
had a sample Δ9-THC concentration of  >0  ng/mL as 
determined by LC/MSMS and current response above or 
below the cut-off (Fig. 10).
The device sensitivity, selectivity and accuracy were 
defined as:
Table 1 %CV of  response, all donors, for  the responses 
in Fig. 5
%CV all donor responses, using average current over time (t)
0.0–0.025 0.025–0.05 0.05–0.075 0.075–0.10 0.10–0.125
A −16.3 −26.5 −30.9 −32.8 −34.3
B −7.9 −6.2 −10.2 −18.6 −32.3




Table 2 shows the sensor performance at different time 
points on the CA3-CA1 response.
It can be seen from Table 2 there was a sweet spot for 
maximum sensitivity of response to Δ9-THC at 0.05–
0.075  s giving sensitivity, selectivity and accuracy of 28, 
99 and 52  % respectively. The number of false positives 
was very low i.e. samples containing no Δ9-THC were 
accurately assigned. However the number of false nega-
tives was high, reflecting the relatively small concentra-
tion range within which the sensor responds to Δ9-THC.
Experimental
Δ9-THC was purchased as 1  mg/mL solution in meth-
anol (Cerilliant, T-005) and the mediator OX0245 
(PH010250) were obtained from Sigma-Aldrich Co. 
Ltd (Poole, UK). All other chemicals were purchased 
from Sigma-Aldrich Co. Ltd. All chemicals were used as 
received without further purification. All solutions were 
Fig. 6 Chronoamperometric reduction response to OX0245, using potentiostatic or galvanostatic oxidation. Each data point represents the average 
current response obtained from 6 sensors, averaged over the time intervals 0.05–0.15, 0.15–0.25, 0.25–0.35, 0.95–1.05 and 1.45–1.55 s. Error bars are 
one standard deviation. 15 uL of solution containing 0.1, 0.5 or 2 mg/mL OX0245 in 0.04 M AMPSO solution (pH 9.5) 0.1 M NaCl and 0.002 % TX‑100 
was pipetted onto a sensor. The procedure used a 5 s wait time, then a galvanostatic oxidation at 100 nA for 5 s or b potentiostatic oxidation at 
+0.3 V for 5 s, followed by chronoamperometric reduction at −0.1 V for 2 s, with a sample rate of 2.5 ms
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prepared using deionized water with resistivity no less 
than 18.2 MΩ cm.
Screen printed electrodes were fabricated in house 
with appropriate stencil designs using a DEK horizon 
printing machine (DEK, Weymouth, UK). Successive lay-
ers of carbon-graphite ink (C2110406D4), dielectric ink 
(D2070423P5) and Ag/AgCl ink (60:40, C2030812P3) 
obtained from Gwent Electronic Materials Ltd. 
(Pontypool, UK) were printed onto a polyester substrate. 
The layers were cured using a tunnel drier at 70 °C (Nat-
graph, Nottingham, UK).
The overlayer material was composed of abaca and 
cellulosic fibres (75 %) in a polypropylene thermoplastic 
matrix (25  %), dry weight 16.5  g/m2 (CD020010, Ahl-
strom) in reel format (1  cm wide) was obtained from 
Ahlstrom (Duns, UK). The overlayer was coated with 
Fig. 7 Effect of varying the magnitude of the galvanostatic current on the CA3‑CA1 response. Each data point is the average current response of 6 
sensors averaged over 0.05–0.15 s. The error bars are one standard deviation. The overlayer was treated with 1 mg/mL OX0245 in 0.4 M AMPSO (pH 
9.5), 1 M NaCl, 1 % TX‑100 and 0.5 % Surfynol 465. 7 uL of saliva obtained from one donor was applied to each sensor. The electrochemical protocol 
was as follows: 5 s wait time, CA1 at −0.2 V for 2 s, CA2 at −0.04 V for 0.5 s, galvanostatic current of 0–300 nA for 5 s, followed by CA3 at −0.2 V for 
2 s
Fig. 8 Chronoamperometric response to saliva spiked with Δ9‑THC. Each data point is the average response of 12 sensors averaged over 0.05–
0.075, 0.075–0.1 and 0.1–0.125 s. The error bars are one standard deviation. The overlayer was treated with 1 mg/mL OX0245 in 0.4 M AMPSO (pH 
9.5), 1 M NaCl, 1 % TX‑100 and 0.5 % Surfynol 465. 7 uL of sample was applied to the overlayer. The electrochemical protocol was as follows: 20 s 
wait time, CA1 at −0.2 V for 2 s, CA2 at −0.04 V for 0.5 s, galvanostatic current of 100 nA for 5 s, followed by CA3 at −0.2 V for 2 s
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OX0245 as follows: 1  mg/mL OXO245 was prepared in 
0.4  M AMPSO buffer solution (pH 9.5) containing 1  M 
NaCl, 1 % Triton X-100 and 0.5 % Surfynol 465. The solu-
tion was dispensed onto the membrane at a loading of 
0.1–1 mg/mL and dried at 40 °C. The dried overlayer was 
heat soldered to each sensor along the edges.
Voltammetric measurements were performed using 
a multiautolab M101 (Eco Chemie) potentiostat. The 
screen printed sensors were used as a two electrode sys-
tem, with a combined counter/reference electrode (Ag/
AgCl ink). The sensor format is shown in Fig. 4 with and 
without the overlayer.
Each saliva sample was collected immediately before 
use by spitting into a pot. Saliva sample containing Δ9-
THC was prepared by firstly dispensing a known vol-
ume of 10  ug/mL Δ9-THC/methanol into a glass vial 
Fig. 9 Saliva Δ9‑THC concentrations determined by LC/MSMS for samples from the clinical trial. The samples were obtained from four cannabis 
smoking donors. Time point 0 was before smoking cannabis and the donors smoked a cannabis cigarette between time points 0 and 1. Time points 
1–8 were at 30 min intervals. The upper detection limit of the assay was 1000 ng/mL
Fig. 10 Clinical trial results obtained from 4 cannabis smoking donors and 16 non‑smoking donors. Each data point is the CA3‑CA1 current 
response for one sensor, using the average chronoamperometric transient current response between 0.05–0.075 s. Each sample was tested with 
12 sensors. The solid horizontal line is the average current value of the samples with 0 ng/mL THC. The dotted horizontal line is two standard devia‑
tions from the average current of the 0 ng/mL samples. The sensor format and electrochemical sequence were as described in Fig. 8
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evaporating the methanol, then adding a known volume 
of saliva to achieve the required final THC concentra-
tion. The glass vial was then placed on a roller mixer for 
at least 1  h to dissolve the Δ9-THC before use. A 1  mL 
aliquot of each Δ9-THC/saliva sample was pipetted into 
a Quantisal saliva collection device (Agriyork 400 Ltd, 
Pocklington, UK) and sent for quantitative analysis by 
LC/MSMS by Synergy Health (Gwent, UK). The assay 
reportable range was <0.25–1000 ng/mL.
Saliva buffer, which mimics real saliva except for the 
absence of proteins, consisted of 27.5 mM sodium chlo-
ride, 6.3 mM ammonium chloride, 4.9 mM sodium phos-
phate (monobasic), 2.9 mM potassium chloride, 1.1 mM 
sodium citrate (anhydrous), 0.02  mM magnesium 
chloride (anhydrous), 0.27  mM sodium carbonate and 
0.2  mM calcium chloride. Artificial saliva was prepared 
using saliva buffer with the addition of 0.3 mg/mL human 
recombinant lysozyme (Sigma, L1667) and 0.021 mg/mL 
mucin from bovine submaxillary glands (Sigma, M3895).
A trial of the sensors was conducted with fresh sam-
ples from cannabis smokers at SWOV Institute for Road 
Safety Research, The Hague, Netherlands. Ethical con-
sent was obtained for the trial. Prior to smoking, a saliva 
sample was obtained from each of four donors. Each 
donor then smoked a cannabis cigarette containing an 
unknown quantity of THC. After smoking saliva samples 
were collected from each donor at 30  min intervals for 
the following 4 h. The donors were allowed to sip water 
during the trial. Sixteen samples were also collected from 
non-smoking donors. A 1 mL aliquot of each sample was 
placed in a Quantisal collection tube and sent for analysis 
of Δ9-THC content using LC/MSMS by Synergy Health.
Conclusions
The detection of 25–50  ng/mL Δ9-THC in undiluted 
saliva has been reported using mediated disposable 
screen printed sensors with a response time of 30  s. 
The sensors used a triple chronoamperometric method 
combined with galvanostatic oxidation of the mediator to 
reduce the effect of donor variation in response, however 
some variation remained and further optimization of the 
sensor is required.
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